Hypothesis

Aging operates as an evolved bet‑hedging strategy that links the continuation of developmental growth programs (the "shadow" of mTOR‑driven pathways) to fluctuations in extrinsic mortality, thereby adjusting somatic maintenance to maximize inclusive fitness across unpredictable environments.

Mechanistic basis

• Developmental programs that promote growth and reproduction are orchestrated by mTORC1 signaling. In many species these pathways are not fully attenuated after maturation, leaving a residual activity that drives cellular senescence, stem‑cell exhaustion, and chronic inflammation – the quasi‑programmed aging phenotype described by Blagosklonny 7.
• Extrinsic mortality cues (predator odor, population density, pathogen load) are sensed via conserved neuroendocrine axes (e.g., IGF‑1, glucocorticoids) that directly modulate mTORC1 activity 6.
• When extrinsic risk is high, the organism benefits from allocating resources to rapid reproduction rather than long‑term tissue upkeep. Elevated mTORC1 sustains the developmental shadow, accelerating senescence and freeing resources for kin. When risk is low, attenuated mTORC1 permits greater somatic maintenance, extending lifespan.

Testable predictions

1. Environmental manipulation – In model organisms (e.g., Nothobranchius furzeri killifish or Drosophila melanogaster), exposing juveniles to predator‑derived cues will increase mTORC1 phosphorylation (measured by p‑S6K) and advance the onset of senescence markers (SA‑β‑gal, p16^INK4a^) compared with controls kept in low‑risk conditions. Conversely, reducing perceived risk will delay these markers.
2. Genetic perturbation – Tissue‑specific knockdown of mTORC1 components (Raptor or S6K) in high‑risk environments will extend lifespan without compromising early‑life fecundity, whereas the same manipulation in low‑risk settings will yield little or no lifespan extension because the developmental shadow is already subdued.
3. Falsifiable outcome – If exogenous activation of mTORC1 (e.g., via Rheb overexpression) fails to accelerate senescence markers under low‑risk conditions, or if lifespan extension from mTORC1 inhibition is absent in high‑risk settings, the hypothesis is refuted.

Experimental approach

• Establish parallel populations of killifish housed with or without visual/olfactory predator signals.
• Quantify mTORC1 activity (Western blot for p‑S6K, p‑4EBP1), senescence (SA‑β‑gal staining, p16^INK4a^ qPCR), and reproductive output across ages.
• Apply rapamycin or genetic Raptor RNAi at defined ages and track survival curves.
• Perform reciprocal transplants to test whether the effect is reversible when mortality cues are switched.

Implications

If validated, this framework reframes aging interventions: rather than universally suppressing mTOR, therapies could be tailored to an individual's extrinsic mortality profile, negotiating with the evolved bet‑hedging logic instead of opposing it. It also predicts that longevity gains from mTOR inhibition will be context dependent, explaining heterogeneous outcomes across species and human cohorts.

References

[1] https://www.fightaging.org/archives/2010/01/a-defense-of-programmed-aging/ [2] https://pubmed.ncbi.nlm.nih.gov/19202326/ [3] https://pmc.ncbi.nlm.nih.gov/articles/PMC10708185/ [4] https://pmc.ncbi.nlm.nih.gov/articles/PMC4803632/ [5] https://elifesciences.org/reviewed-preprints/92914/ [6] https://pmc.ncbi.nlm.nih.gov/articles/PMC10435286/ [7] https://pmc.ncbi.nlm.nih.gov/articles/PMC3905065/